Daclizumab (Zenapax®) inhibits early interleukin-2 receptor signal transduction events

Autor: Goebel, Jens *, Stevens, Erica, Forrest, Kathy, Roszman, Thomas L
Zdroj: In Transplant Immunology 2000 8(3):153-159
Databáze: ScienceDirect